Citigroup Inc Genetron Holdings LTD Transaction History

Citigroup Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	SELL	$0.91 - $1.69 $0 - $1	-1 Reduced 1.75%	56 $0
Q2 2022 Aug 10, 2022	SELL	$1.28 - $2.4 $38,667 - $72,501	-30,209 Reduced 99.81%	57 $0
Q1 2022 May 12, 2022	SELL	$2.19 - $6.09 $17,631 - $49,030	-8,051 Reduced 21.01%	30,266 $66,000
Q4 2021 Feb 10, 2022	BUY	$5.81 - $14.39 $11,108 - $27,513	1,912 Added 5.25%	38,317 $234,000
Q3 2021 Nov 10, 2021	BUY	$11.55 - $20.3 $420,477 - $739,021	36,405 New	36,405 $504,000

7.5K

Ticker GTH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 90,602,304
Description
Genetron Holdings Limited, a precision oncology company, engages in the cancer molecular profiling, and harnessing technologies in molecular biology and data science for cancer treatment. The company offers diagnosis and monitoring services, and early screening services through laboratory developed tests services. It also provides in-vitro diagn...

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

Stay updated on Citigroup Inc with notifications on news.